Ma CX - Search Results

1

Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy.

Kennedy WR, Tricarico C, Gabani P, Weiner AA, Altman MB, Ochoa LL, Thomas MA, Margenthaler JA, Sanati S, Peterson LL, Ma CX, Ademuyiwa FO, Zoberi I. Kennedy WR, et al. Among authors: ma cx. J Natl Compr Canc Netw. 2020 Mar;18(3):288-296. doi: 10.6004/jnccn.2019.7366. J Natl Compr Canc Netw. 2020. PMID: 32135512

2

Predicting endocrine therapy responsiveness in breast cancer.

Ma CX, Sanchez CG, Ellis MJ. Ma CX, et al. Oncology (Williston Park). 2009 Feb;23(2):133-42. Oncology (Williston Park). 2009. PMID: 19323294 Free article. Review.

3

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.

Aft R, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, Zhai J, Kuo S, Shannon W, Diemer K, Herrmann V, Dietz J, Ali A, Ellis M, Weiss P, Eberlein T, Ma C, Fracasso PM, Zoberi I, Taylor M, Gillanders W, Pluard T, Mortimer J, Weilbaecher K. Aft R, et al. Lancet Oncol. 2010 May;11(5):421-8. doi: 10.1016/S1470-2045(10)70054-1. Epub 2010 Mar 31. Lancet Oncol. 2010. PMID: 20362507 Free PMC article. Clinical Trial.

4

Neoadjuvant endocrine therapy for breast cancer.

Chawla JS, Ma CX, Ellis MJ. Chawla JS, et al. Among authors: ma cx. Surg Oncol Clin N Am. 2010 Jul;19(3):627-38. doi: 10.1016/j.soc.2010.04.004. Surg Oncol Clin N Am. 2010. PMID: 20620931 Review.

5

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.

Chia YH, Ellis MJ, Ma CX. Chia YH, et al. Among authors: ma cx. Br J Cancer. 2010 Sep 7;103(6):759-64. doi: 10.1038/sj.bjc.6605845. Epub 2010 Aug 10. Br J Cancer. 2010. PMID: 20700118 Free PMC article. Review.

6

Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response.

Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA. Fisher CS, et al. Among authors: ma cx. Ann Surg Oncol. 2012 Jan;19(1):253-8. doi: 10.1245/s10434-011-1877-y. Epub 2011 Jul 2. Ann Surg Oncol. 2012. PMID: 21725686 Free PMC article.

7

Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer.

Goncalves R, Ma C, Luo J, Suman V, Ellis MJ. Goncalves R, et al. Nat Rev Clin Oncol. 2012 Feb 28;9(4):223-9. doi: 10.1038/nrclinonc.2012.21. Nat Rev Clin Oncol. 2012. PMID: 22371132 Free PMC article. Review.

8

Racial differences in outcomes of triple-negative breast cancer.

Pacheco JM, Gao F, Bumb C, Ellis MJ, Ma CX. Pacheco JM, et al. Among authors: ma cx. Breast Cancer Res Treat. 2013 Feb;138(1):281-9. doi: 10.1007/s10549-012-2397-6. Epub 2013 Feb 12. Breast Cancer Res Treat. 2013. PMID: 23400579 Free PMC article.

9

Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: challenges and considerations.

Nagaraj G, Ma CX. Nagaraj G, et al. Among authors: ma cx. J Natl Compr Canc Netw. 2013 Mar 1;11(3):246-50; quiz 251. doi: 10.6004/jnccn.2013.0036. J Natl Compr Canc Netw. 2013. PMID: 23486451

10

Neoadjuvant therapy in operable breast cancer: application to triple negative breast cancer.

Ademuyiwa FO, Ellis MJ, Ma CX. Ademuyiwa FO, et al. Among authors: ma cx. J Oncol. 2013;2013:219869. doi: 10.1155/2013/219869. Epub 2013 Aug 1. J Oncol. 2013. PMID: 23983689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters